IN2014CN02128A - - Google Patents

Info

Publication number
IN2014CN02128A
IN2014CN02128A IN2128CHN2014A IN2014CN02128A IN 2014CN02128 A IN2014CN02128 A IN 2014CN02128A IN 2128CHN2014 A IN2128CHN2014 A IN 2128CHN2014A IN 2014CN02128 A IN2014CN02128 A IN 2014CN02128A
Authority
IN
India
Prior art keywords
animal
compositions
endoparasites
infestations
eradicating
Prior art date
Application number
Inventor
Mark D Soll
Joseph K Rosentel
James Pate
Natalya Shub
Motwani Monica Tejwani
Carol Belansky
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47018471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN02128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of IN2014CN02128A publication Critical patent/IN2014CN02128A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N49/00—Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean —Y— or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

This invention relates to topical compositions for combating ectoparasites and endoparasites in animals comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating controlling and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.
IN2128CHN2014 2011-09-12 2012-09-12 IN2014CN02128A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161533308P 2011-09-12 2011-09-12
PCT/US2012/054719 WO2013039948A1 (en) 2011-09-12 2012-09-12 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof

Publications (1)

Publication Number Publication Date
IN2014CN02128A true IN2014CN02128A (en) 2015-05-29

Family

ID=47018471

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2128CHN2014 IN2014CN02128A (en) 2011-09-12 2012-09-12

Country Status (41)

Country Link
US (6) US9180121B2 (en)
EP (3) EP2755473B1 (en)
JP (3) JP6366102B2 (en)
KR (3) KR102081036B1 (en)
CN (3) CN106943399B (en)
AP (1) AP2014007508A0 (en)
AR (3) AR087838A1 (en)
AU (5) AU2012308776B2 (en)
BR (2) BR122019001738B1 (en)
CA (1) CA2848317C (en)
CL (2) CL2014000601A1 (en)
CO (1) CO6910187A2 (en)
CR (2) CR20180572A (en)
CY (2) CY1121402T1 (en)
DK (2) DK2755473T3 (en)
EA (3) EA026947B1 (en)
ES (2) ES2715000T3 (en)
FR (1) FR21C1025I2 (en)
HK (1) HK1232073A1 (en)
HR (2) HRP20190426T1 (en)
HU (3) HUE052594T2 (en)
IL (4) IL231358A (en)
IN (1) IN2014CN02128A (en)
LT (3) LT2755473T (en)
MA (1) MA35431B1 (en)
ME (1) ME03347B (en)
MX (2) MX364978B (en)
NO (1) NO2021026I1 (en)
NZ (1) NZ725115A (en)
PE (1) PE20142292A1 (en)
PH (1) PH12018501647A1 (en)
PL (2) PL3172964T3 (en)
PT (2) PT3172964T (en)
RS (2) RS58417B1 (en)
SG (2) SG11201400558YA (en)
SI (2) SI3172964T1 (en)
TN (1) TN2014000105A1 (en)
TR (1) TR201903499T4 (en)
TW (2) TWI632135B (en)
WO (1) WO2013039948A1 (en)
ZA (1) ZA201401672B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2507210B (en) 2011-07-13 2020-09-02 Clarke Mosquito Control Products Inc Insecticidal compositions and methods of using the same
KR102081036B1 (en) * 2011-09-12 2020-02-24 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
LT2811998T (en) * 2012-02-06 2019-02-25 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically acting active agents, methods and uses thereof
EP2833867B2 (en) 2012-04-04 2023-05-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
CN105451771B (en) 2013-03-15 2020-05-19 阿根塔创新有限公司 Chewable formulation
PT3063144T (en) * 2013-11-01 2021-10-28 Boehringer Ingelheim Animal Health Usa Inc Antiparisitic and pesticidal isoxazoline compounds
ES2950885T3 (en) 2013-12-20 2023-10-16 Intervet Int Bv Use of isoxazoline compounds in poultry
CN105813651B (en) * 2013-12-20 2021-11-23 英特维特国际股份有限公司 Isoxazoline compositions and their use in preventing or treating parasitic infestations of animals
GB2523811A (en) * 2014-03-06 2015-09-09 Norbrook Lab Ltd Novel Isoxazolines and their uses
CN104095871A (en) * 2014-07-10 2014-10-15 青岛蔚蓝生物股份有限公司 Veterinary injection containing lincomycin hydrochloride and spectinomycin sulfate
WO2016102437A1 (en) * 2014-12-22 2016-06-30 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
EP3253201B1 (en) * 2015-02-03 2020-07-22 Bimeda Finance S.A.R.L. A formulation for treatment of blowfly strike
UY36570A (en) 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
SG11201708068PA (en) * 2015-04-08 2017-10-30 Merial Inc Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
WO2016207234A1 (en) * 2015-06-23 2016-12-29 Intervet International B.V. Isoxazoline solution containing vitamin e for use with sanitized drinking water
UY37137A (en) 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
CN109071283B (en) * 2016-04-26 2022-03-04 奥加诺株式会社 Water treatment agent composition and water treatment method
US20170333305A1 (en) * 2016-05-23 2017-11-23 Microban Products Company Topical skin product having retention property
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
JP2019535655A (en) 2016-10-14 2019-12-12 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド Insecticidal and parasiticidal vinylisoxazoline compounds
WO2018148691A1 (en) * 2017-02-13 2018-08-16 Clarke Mosquito Control Products, Inc. Insecticidal composition
KR102612648B1 (en) * 2017-04-05 2023-12-11 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Crystalline form of (S)-apoxolaner
US10420109B2 (en) * 2017-04-13 2019-09-17 Futurewei Technologies, Inc. System and method for providing explicit feedback in communications systems with multi-point connectivity
ES2944616T3 (en) 2017-08-14 2023-06-22 Boehringer Ingelheim Animal Health Usa Inc Pyrazole-Isoxazoline Compounds Pesticides and Parasiticides
BR112020012018A2 (en) 2017-12-15 2020-11-24 Tarsus Pharmaceuticals, Inc. isoxazoline parasiticide formulations and methods to treat blepharitis
AR113997A1 (en) 2017-12-21 2020-07-08 Intervet Int Bv ANTIPARASITIC COMPOSITIONS FOR CONTINUOUS DORSAL ANOINTING
RU2676326C1 (en) * 2017-12-26 2018-12-28 Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" Complex antibacterial antihelminthic composition for treatment of farm animals and birds
TWI812673B (en) * 2018-02-12 2023-08-21 美商富曼西公司 Naphthalene isoxazoline compounds for controlling invertebrate pests
GB201809374D0 (en) * 2018-06-07 2018-07-25 Fish Vet Group Norge As Treatment for removing ectoparasites from fish
JP2022538758A (en) * 2019-06-14 2022-09-06 ピードモント アニマル ヘルス インコーポレイテッド Long-acting topical formulations and methods of use thereof
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
JPWO2022118814A1 (en) * 2020-12-01 2022-06-09
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
CN112755049A (en) * 2021-02-05 2021-05-07 哈密市动物疫病预防控制中心 Laxative formula for improving dog cestodiasis excrement detection sensitivity and preparation method thereof
CN114042065B (en) * 2021-11-26 2024-03-15 长沙拜特生物科技研究所有限公司 Compound mebendazole transdermal solution and preparation method thereof
WO2023167248A1 (en) * 2022-03-01 2023-09-07 国立研究開発法人産業技術総合研究所 New pest control method targeting respiratory organ forming mechanism of pests
WO2023183831A1 (en) * 2022-03-22 2023-09-28 Equilibre Biopharmaceuticals Bv Liquid formulations of ivermectin compositions and use in gelatin dosage forms

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL160809C (en) 1970-05-15 1979-12-17 Duphar Int Res METHOD FOR PREPARING BENZOYLURUM COMPOUNDS, AND METHOD FOR PREPARING INSECTICIDE PREPARATIONS BASED ON BENZOYLURUM COMPOUNDS.
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
JPS4914624A (en) 1972-06-08 1974-02-08
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
SE434277B (en) 1976-04-19 1984-07-16 Merck & Co Inc SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS
CH604517A5 (en) 1976-08-19 1978-09-15 Ciba Geigy Ag
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
JPS59199673A (en) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd Nitrogen-containing heterocyclic compound, its preparation and pesticide containing the same
DE3580444D1 (en) 1984-10-18 1990-12-13 Ciba Geigy Ag Benzoylphenylharnstoffe.
ATE67493T1 (en) 1985-02-04 1991-10-15 Bayer Agrochem Kk HETEROCYCLIC COMPOUNDS.
DE3603799A1 (en) 1986-02-07 1987-08-13 Philips Patentverwaltung CURRENT MIRROR SWITCHING
EP0237482A1 (en) 1986-03-06 1987-09-16 Ciba-Geigy Ag Derivatives of C(29)-carbonyloxy-milbemycine against parasites in animals and plants
RU2024527C1 (en) 1986-03-25 1994-12-15 Санкио Компани Лимитед Method of macrolide compounds synthesis
GB8613914D0 (en) 1986-06-07 1986-07-09 Coopers Animal Health Liquid formulations
DE3778768D1 (en) 1986-07-02 1992-06-11 Ciba Geigy Ag PESTICIDES.
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (en) 1987-11-03 1994-07-21 Beecham Group Plc Intermediates for the production of macrolide antibiotics with an anthelmintic effect.
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
NZ247278A (en) 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
US5345377A (en) 1992-10-30 1994-09-06 Electric Power Research Institute, Inc. Harmonic controller for an active power line conditioner
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
DE4405898A1 (en) * 1994-02-18 1995-08-24 Schering Ag Transdermal therapeutic systems containing sex steroids
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
MY113806A (en) 1995-07-21 2002-05-31 Upjohn Co Antiparasitic marcfortines and paraherquamides
FR2739255B1 (en) 1995-09-29 1998-09-04 Rhone Merieux PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
FR2752525B1 (en) 1996-08-20 2000-05-05 Rhone Merieux METHOD FOR CONTROLLING MYIA OF CATTLE AND SHEEP HERBS AND COMPOSITIONS FOR CARRYING OUT SAID METHOD
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (en) 1996-09-19 1999-09-24 Rhone Merieux NOVEL PARASITICIDE ASSOCIATION BASED ON 1-N-PHENYLPYRAZOLES AND ENDECTOCIDAL MACROCYCLIC LACTONES
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
JPH1149669A (en) * 1997-08-05 1999-02-23 Nitto Denko Corp Antiviral agent-containing tape preparation
JP4237293B2 (en) * 1998-05-19 2009-03-11 東光薬品工業株式会社 Transdermal patch
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
PE20011289A1 (en) 2000-04-07 2001-12-21 Upjohn Co ANTIHELMINE COMPOSITIONS INCLUDING MACROCYCLIC AND SPIRODIOXEPINOINDOLES LACTONES
CA2311881C (en) 2000-06-16 2007-08-28 Gary O. Maupin Control of arthropods in rodents
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
TW200409760A (en) 2002-09-11 2004-06-16 Novartis Ag Organic compounds
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7262214B2 (en) 2003-02-26 2007-08-28 Merial Limited 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
JP2004269368A (en) * 2003-03-05 2004-09-30 Ogawa & Co Ltd Cold sense agent composition and cold sense cosmetic comprising the same cold sense agent composition
BRPI0409185B1 (en) 2003-04-04 2018-05-15 Merial, Inc TOPICAL ANTI-HELMINTIC VETERINARY FORMULATIONS
JP4405765B2 (en) * 2003-08-04 2010-01-27 大阪化成株式会社 Indoor acaricide
US7807696B2 (en) 2003-10-07 2010-10-05 The Feinstein Institute For Medical Research Isoxazole and isothiazole compounds useful in the treatment of inflammation
US7531186B2 (en) 2003-12-17 2009-05-12 Merial Limited Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
EA011764B1 (en) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Isoxazoline-substituted benzamide compound and pesticide
US20050232876A1 (en) * 2004-04-19 2005-10-20 Robin Lynn Minga Skin care compositions
PE20060785A1 (en) * 2004-10-08 2006-09-19 Wyeth Corp AMITRAZ COMPOSITIONS
JP2008540508A (en) * 2005-05-09 2008-11-20 フォーミックス エルティーディー． Foaming vehicle and pharmaceutical composition thereof
US20060293260A1 (en) 2005-05-24 2006-12-28 Wyeth Useful high load concentrate compositions for control of ecto-and endo-parasites
KR101416521B1 (en) 2005-09-02 2014-07-16 닛산 가가쿠 고교 가부시키 가이샤 Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
KR20080080168A (en) 2005-12-14 2008-09-02 이 아이 듀폰 디 네모아 앤드 캄파니 Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
DE602007006288D1 (en) 2006-03-10 2010-06-17 Nissan Chemical Ind Ltd SUBSTITUTED ISOXAZOLIN COMPOUND AND PESTICIDES
MX2008013307A (en) 2006-04-20 2008-10-27 Du Pont Pyrazolines for controlling invertebrate pests.
JP2008044880A (en) 2006-08-15 2008-02-28 Bayer Cropscience Ag Insecticidal isooxazolines
KR20150112041A (en) * 2006-09-01 2015-10-06 이 아이 듀폰 디 네모아 앤드 캄파니 Local topical administration formulations containing indoxacarb
EP2115185B1 (en) 2007-02-26 2015-11-11 LG Chem, Ltd. Conductive laminated body and method for preparing the same
EP2151437A4 (en) 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide compound and pest control agent
JP5256753B2 (en) 2007-03-29 2013-08-07 住友化学株式会社 Isoxazoline compounds and their pest control applications
KR20090130064A (en) 2007-04-10 2009-12-17 바이엘 크롭사이언스 아게 Insecticidal aryl isoxazoline derivatives
LT3428148T (en) 2007-05-15 2020-10-12 Boehringer Ingelheim Animal Health USA Inc. Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
AU2008261793A1 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
EP2455755A3 (en) 2007-06-22 2012-08-15 GENERA ISTRAZIVANJA d.o.o. Proteaoglycan-4 as marker for chronic renal failure
TWI430995B (en) * 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
CN105640952A (en) 2007-06-27 2016-06-08 杜邦公司 Animal pest control method
EP2172448A4 (en) 2007-06-29 2012-01-11 Nissan Chemical Ind Ltd Substituted isoxazoline or enone oxime compound, and pest control agent
WO2009004432A1 (en) 2007-06-29 2009-01-08 Pfizer Inc. Anthelmintic combination
JP2010535231A (en) 2007-07-31 2010-11-18 ワイス・エルエルシー Internal parasite control topical composition
TWI556741B (en) 2007-08-17 2016-11-11 英特威特國際股份有限公司 Isoxazoline compositions and their use as antiparasitics
TW200924647A (en) 2007-08-30 2009-06-16 Schering Plough Ltd Local topical administration formulations containing fipronil
KR20100064382A (en) 2007-09-10 2010-06-14 닛산 가가쿠 고교 가부시키 가이샤 Substituted isoxazoline compound and pest control agent
WO2009045999A1 (en) 2007-10-03 2009-04-09 E. I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
EP2306837B2 (en) 2008-07-09 2023-10-25 Basf Se Pesticidal active mixtures comprising isoxazoline compounds i
WO2010003877A1 (en) 2008-07-09 2010-01-14 Basf Se Pesticidal mixtures comprising isoxazoline compounds ii
CN102143960A (en) 2008-09-04 2011-08-03 先正达参股股份有限公司 Insecticidal compounds
CN102239151B (en) 2008-10-21 2014-07-02 梅里亚有限公司 Thioamide compounds, method of making and method of using thereof
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
CN102325759A (en) 2008-12-23 2012-01-18 巴斯夫欧洲公司 Substituted amidine compounds for combating animal pests
US20110288089A1 (en) 2009-01-22 2011-11-24 Syngenta Crop Protection Llc Insecticidal compounds
US20120030841A1 (en) 2009-04-01 2012-02-02 Basf Se Isoxazoline compounds for combating invertebrate pests
CN101940790B (en) * 2009-07-01 2012-07-25 润和生物医药科技(汕头)有限公司 Novel penetration-promoting agent composition and application thereof to transdermal administration system
TWI487486B (en) 2009-12-01 2015-06-11 Syngenta Participations Ag Insecticidal compounds based on isoxazoline derivatives
WO2011075591A1 (en) * 2009-12-17 2011-06-23 Merial Limited Anti parasitic dihydroazole compounds and compositions comprising same
EP2531493B1 (en) 2010-02-01 2015-07-22 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
EP2538788A1 (en) 2010-02-25 2013-01-02 Syngenta Participations AG Pesticidal mixtures containing isoxazoline derivatives and insecticide or nematoicidal biological agent
UA108641C2 (en) 2010-04-02 2015-05-25 PARASITICID COMPOSITION CONTAINING FOUR ACTIVE AGENTS AND METHOD OF APPLICATION
EP2576523B1 (en) * 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
BR112012031277A2 (en) 2010-06-09 2016-09-27 Syngenta Participations Ag "pesticide mixtures comprising isoxazoline derivatives"
EP2579725A2 (en) 2010-06-09 2013-04-17 Syngenta Participations AG Pesticidal mixtures including isoxazoline derivatives
WO2011154433A2 (en) 2010-06-09 2011-12-15 Syngenta Participations Ag Pesticidal mixtures including isoxazoline derivatives
DK178277B1 (en) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazoline compounds for the control of fish lice
WO2012007426A1 (en) 2010-07-13 2012-01-19 Basf Se Azoline substituted isoxazoline benzamide compounds for combating animal pests
NZ606194A (en) 2010-08-05 2013-12-20 Zoetis Services Llc Isoxazoline derivatives as antiparasitic agents
EP2619189B1 (en) * 2010-09-24 2020-04-15 Zoetis Services LLC Isoxazoline oximes as antiparasitic agents
RU2602189C2 (en) 2010-12-27 2016-11-10 Интервет Интернэшнл Б.В. Topical localized isoxazoline formulation comprising glycofurol
BR112013015503A2 (en) 2010-12-27 2017-06-27 Intervet Int Bv topical localized formulation, use of a formulation, and method for treating or prophylaxing an animal's parasite infestation
KR102081036B1 (en) * 2011-09-12 2020-02-24 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
LT2811998T (en) * 2012-02-06 2019-02-25 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically acting active agents, methods and uses thereof

Also Published As

Publication number Publication date
DK2755473T3 (en) 2019-03-11
AU2019203419A1 (en) 2019-06-06
KR101968489B1 (en) 2019-04-12
KR20190038681A (en) 2019-04-08
PT2755473T (en) 2019-03-25
EA201892754A1 (en) 2019-05-31
AR117163A2 (en) 2021-07-14
CL2014000601A1 (en) 2014-10-10
CA2848317A1 (en) 2013-03-21
BR112014005514B1 (en) 2019-12-03
NO2021026I1 (en) 2021-06-22
US10383854B2 (en) 2019-08-20
ME03347B (en) 2019-10-20
PT3172964T (en) 2020-11-30
CR20180572A (en) 2019-02-01
IL249830A0 (en) 2017-02-28
CN103957701B (en) 2017-05-03
EP2755473A1 (en) 2014-07-23
JP2018154660A (en) 2018-10-04
PH12018501647A1 (en) 2019-02-27
AU2021204688A1 (en) 2021-07-29
ZA201401672B (en) 2015-02-25
US20210128533A1 (en) 2021-05-06
AU2016202105B2 (en) 2017-06-29
HUE042360T2 (en) 2019-06-28
IL240283A (en) 2017-02-28
EA026947B1 (en) 2017-06-30
AR122776A2 (en) 2022-10-05
RS61048B1 (en) 2020-12-31
US10786487B2 (en) 2020-09-29
CN106943399A (en) 2017-07-14
AU2017228622B2 (en) 2019-02-28
TWI632135B (en) 2018-08-11
BR122019001738B1 (en) 2019-11-05
HRP20201745T1 (en) 2020-12-25
HRP20190426T1 (en) 2019-04-19
MX364978B (en) 2019-05-16
HUS2100024I1 (en) 2021-07-28
US9877950B2 (en) 2018-01-30
TR201903499T4 (en) 2019-04-22
FR21C1025I1 (en) 2021-08-06
IL231358A0 (en) 2014-04-30
JP2020203891A (en) 2020-12-24
HK1232073A1 (en) 2018-01-05
EA201790094A1 (en) 2017-05-31
LT2755473T (en) 2019-03-12
EA201400340A1 (en) 2014-08-29
NZ622466A (en) 2015-10-30
PL2755473T3 (en) 2019-05-31
CY1123701T1 (en) 2021-09-14
ES2834427T3 (en) 2021-06-17
KR20200019793A (en) 2020-02-24
BR112014005514A2 (en) 2017-03-21
CR20140117A (en) 2014-06-12
SG11201400558YA (en) 2014-04-28
AU2019203419B2 (en) 2021-04-08
CY1121402T1 (en) 2020-05-29
AU2016202105A1 (en) 2016-04-28
AU2017228622A1 (en) 2017-10-05
NZ742345A (en) 2020-05-29
EP3172964A1 (en) 2017-05-31
EA038853B1 (en) 2021-10-28
US11464763B2 (en) 2022-10-11
TW201317219A (en) 2013-05-01
TWI567064B (en) 2017-01-21
IL231358A (en) 2016-04-21
IL268295B (en) 2020-06-30
AP2014007508A0 (en) 2014-03-31
CN106474120A (en) 2017-03-08
US20160051519A1 (en) 2016-02-25
LTPA2021006I1 (en) 2021-07-12
CL2015000630A1 (en) 2015-07-17
NZ725115A (en) 2018-08-31
LT3172964T (en) 2020-12-10
HUE052594T2 (en) 2021-05-28
CN103957701A (en) 2014-07-30
PE20142292A1 (en) 2015-01-10
SG10201606670WA (en) 2016-10-28
MX2014002904A (en) 2014-05-07
PL3172964T3 (en) 2021-03-08
DK3172964T3 (en) 2020-11-30
CN106943399B (en) 2020-07-28
LTC3172964I2 (en) 2023-03-10
SI3172964T1 (en) 2020-12-31
FR21C1025I2 (en) 2023-02-17
EP3172964B1 (en) 2020-08-26
JP6946528B2 (en) 2021-10-06
KR20140061530A (en) 2014-05-21
MX2019003906A (en) 2019-12-09
CA2848317C (en) 2021-01-19
JP6366102B2 (en) 2018-08-01
TW201702235A (en) 2017-01-16
EP2755473B1 (en) 2018-12-12
CN106474120B (en) 2020-07-28
ES2715000T3 (en) 2019-05-31
JP2014527081A (en) 2014-10-09
US20190216784A1 (en) 2019-07-18
RS58417B1 (en) 2019-04-30
MA35431B1 (en) 2014-09-01
AU2012308776A1 (en) 2014-04-03
AR087838A1 (en) 2014-04-23
US20130065846A1 (en) 2013-03-14
US9180121B2 (en) 2015-11-10
WO2013039948A1 (en) 2013-03-21
KR102081036B1 (en) 2020-02-24
CO6910187A2 (en) 2014-03-31
AU2012308776B2 (en) 2016-04-14
IL240283A0 (en) 2015-09-24
EA032162B1 (en) 2019-04-30
IL249830B (en) 2019-08-29
TN2014000105A1 (en) 2015-07-01
US20170020849A1 (en) 2017-01-26
US20230087923A1 (en) 2023-03-23
SI2755473T1 (en) 2019-03-29
EP3788874A1 (en) 2021-03-10
IL268295A (en) 2019-09-26

Similar Documents

Publication Publication Date Title
IN2014CN02128A (en)
TN2014000336A1 (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
MY161635A (en) Parasiticidal compositions comprising multiple active agents, methods and uses thereof
PH12014502345A1 (en) Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof